UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
(Mark One)
| þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
OR
| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission file number 0-26844
RADISYS CORPORATION
| OREGON (State or other jurisdiction of Incorporation or Organization) |
93-0945232 (I.R.S. Employer Identification Number) |
5445 N.E. Dawson Creek Drive
Hillsboro, OR 97124
(Address of principal executive offices, including zip code)
(503) 615-1100
(Registrants telephone number, including area code)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act) Yes þ No o
Number of shares of Common Stock outstanding as of April 30, 2004: 18,740,339
RADISYS CORPORATION
FORM 10-Q
TABLE OF CONTENTS
| Page |
||||||||
| 2 | ||||||||
| 3 | ||||||||
| 4 | ||||||||
| 5 | ||||||||
| 6 | ||||||||
| 19 | ||||||||
| 35 | ||||||||
| 37 | ||||||||
| 37 | ||||||||
| 38 | ||||||||
| EXHIBIT 10.1 | ||||||||
| EXHIBIT 31.1 | ||||||||
| EXHIBIT 31.2 | ||||||||
| EXHIBIT 32.1 | ||||||||
| EXHIBIT 32.2 | ||||||||
1
PART I. FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements
RADISYS CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
| For the Three Months Ended March 31, |
||||||||
| 2004 |
2003 |
|||||||
Revenues |
$ | 61,115 | $ | 48,404 | ||||
Cost of sales |
42,297 | 33,207 | ||||||
Gross margin |
18,818 | 15,197 | ||||||
Research and development |
6,344 | 5,540 | ||||||
Selling, general, and administrative |
7,677 | 6,548 | ||||||
Intangible assets amortization |
682 | 765 | ||||||
Restructuring charges (reversals) |
(180 | ) | 1,829 | |||||
Income from operations |
4,295 | 515 | ||||||
Gain on repurchase of convertible subordinated notes |
| 825 | ||||||
Interest expense |
(1,426 | ) | (1,209 | ) | ||||
Interest income |
856 | 803 | ||||||
Other income (expense), net |
78 | (492 | ) | |||||
Income from continuing operations before income tax provision |
3,803 | 442 | ||||||
Income tax provision |
955 | 9 | ||||||
Income from continuing operations |
2,848 | 433 | ||||||
Discontinued operations related to Savvi business: |
||||||||
Loss from discontinued operations |
| (4,679 | ) | |||||
Net income (loss) |
$ | 2,848 | $ | (4,246 | ) | |||
Income per share from continuing operations: |
||||||||
Basic |
$ | 0.15 | $ | 0.02 | ||||
Diluted |
$ | 0.15 | $ | 0.02 | ||||
Net income (loss) per share: |
||||||||
Basic |
$ | 0.15 | $ | (0.24 | ) | |||
Diluted |
$ | 0.15 | $ | (0.24 | ) | |||
Weighted average shares outstanding: |
||||||||
Basic |
18,491 | 17,673 | ||||||
Diluted |
19,447 | 17,840 | ||||||
The accompanying notes are an integral part of these financial statements.
2
RADISYS CORPORATION
CONSOLIDATED BALANCE SHEETS
| March 31, | December 31, | |||||||
| 2004 |
2003 |
|||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 168,957 | $ | 149,925 | ||||
Short-term investments, net |
41,629 | 44,456 | ||||||
Accounts receivable, net |
36,791 | 32,144 | ||||||
Inventories, net |
21,523 | 26,092 | ||||||
Other current assets |
2,800 | 2,781 | ||||||
Deferred tax assets |
6,898 | 6,898 | ||||||
Total current assets |
278,598 | 262,296 | ||||||
Property and equipment, net |
14,526 | 14,584 | ||||||
Goodwill |
27,521 | 27,521 | ||||||
Intangible assets, net |
5,755 | 6,437 | ||||||
Long-term investments, net |
23,859 | 30,992 | ||||||
Long-term deferred tax assets |
22,017 | 21,911 | ||||||
Other assets |
1,959 | 1,821 | ||||||
Total assets |
$ | 374,235 | $ | 365,562 | ||||
LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 24,068 | $ | 21,969 | ||||
Accrued wages and bonuses |
4,921 | 4,868 | ||||||
Accrued interest payable |
979 | 1,577 | ||||||
Accrued restructuring |
2,174 | 2,820 | ||||||
Other accrued liabilities |
8,399 | 8,738 | ||||||
Total current liabilities |
40,541 | 39,972 | ||||||
Long-term liabilities: |
||||||||
Convertible senior notes, net |
97,047 | 97,015 | ||||||
Convertible subordinated notes, net |
67,657 | 67,585 | ||||||
Total long-term liabilities |
164,704 | 164,600 | ||||||
Total liabilities |
205,245 | 204,572 | ||||||
Shareholders equity : |
||||||||
Common stock no par value, 100,000 shares authorized;
18,644 and 18,274 shares issued and outstanding at
March 31, 2004 and December 31, 2003 |
171,757 | 166,445 | ||||||
Accumulated deficit |
(5,846 | ) | (8,694 | ) | ||||
Accumulated other comprehensive income: |
||||||||
Cumulative translation adjustments |
3,079 | 3,239 | ||||||
Total shareholders equity |
168,990 | 160,990 | ||||||
Total liabilities and shareholders equity |
$ | 374,235 | $ | 365,562 | ||||
The accompanying notes are an integral part of these financial statements.
3
RADISYS CORPORATION
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS EQUITY
| Common Stock | Cumulative | Total other | ||||||||||||||||||||||
| translation | Accumulated | comprehensive | ||||||||||||||||||||||
| Shares |
Amount |
adjustments(1) |
deficit |
Total |
income (loss) (2) |
|||||||||||||||||||
Balances, December 31, 2003 |
18,274 | $ | 166,445 | $ | 3,239 | $ | (8,694 | ) | $ | 160,990 | ||||||||||||||
Shares issued pursuant to benefit plans. |
370 | 4,091 | | | 4,091 | $ | | |||||||||||||||||
Tax benefit of stock-based benefit plans |
| 1,044 | | | 1,044 | | ||||||||||||||||||
Stock-based compensation expense |
| 177 | | | 177 | | ||||||||||||||||||
Translation adjustments |
| | (160 | ) | | (160 | ) | (160 | ) | |||||||||||||||
Net income for the period |
| | | 2,848 | 2,848 | 2,848 | ||||||||||||||||||
Balances, March 31, 2004 |
18,644 | $ | 171,757 | $ | 3,079 | $ | (5,846 | ) | $ | 168,990 | ||||||||||||||
Comprehensive income, for the three
months ended March 31, 2004 |
$ | 2,688 | ||||||||||||||||||||||
| (1) | Income taxes are generally not provided for foreign currency translation adjustments. | |
| (2) | For the three months ended March 31, 2003, other comprehensive loss amounted to $4.1 million and consisted of the net loss for the period of $4.2 million, net income from translation adjustments of $72 thousand, and unrealized gain on a security available for sale of $43 thousand. |
The accompanying notes are an integral part of these financial statements.
4
RADISYS CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
| For the Three Months Ended March 31, |
||||||||
| 2004 |
2003 |
|||||||
Cash flows from operating activities: |
||||||||
Net income (loss) |
$ | 2,848 | $ | (4,246 | ) | |||
Adjustments to reconcile net income (loss) to net cash
provided by operating activities: |
||||||||
Loss on sale of Savvi business |
| 4,286 | ||||||
Depreciation and amortization |
1,993 | 2,584 | ||||||
Provision for inventory reserves |
716 | 1,291 | ||||||
Non-cash restructuring (adjustments) charges |
(180 | ) | | |||||
Non-cash interest expense |
136 | 71 | ||||||
Non-cash amortization of premium on investments |
475 | 543 | ||||||
Loss on disposal of property and equipment |
3 | 252 | ||||||
Gain on early extinguishments of convertible
subordinated notes |
| (825 | ) | |||||
Deferred income taxes |
(106 | ) | 265 | |||||
Stock-based compensation expense |
177 | | ||||||
Tax benefit of stock-based benefit plans |
1,044 | 17 | ||||||
Other |
(88 | ) | 80 | |||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
(4,647 | ) | (2,451 | ) | ||||
Inventories |
3,853 | (4,351 | ) | |||||
Other current assets |
(19 | ) | 613 | |||||
Accounts payable |
2,099 | 2,069 | ||||||
Accrued restructuring |
(466 | ) | (378 | ) | ||||
Accrued interest payable |
(598 | ) | (1,168 | ) | ||||
Accrued wages and bonuses |
53 | (671 | ) | |||||
Other accrued liabilities |
(420 | ) | 2,056 | |||||
Net cash provided by operating activities |
6,873 | 37 | ||||||
Cash flows from investing activities: |
||||||||
Proceeds from sale or maturity of held-to-maturity
investments |
11,780 | 20,176 | ||||||
Purchase of held-to-maturity investments |
(2,295 | ) | (18,547 | ) | ||||
Capital expenditures |
(1,257 | ) | (468 | ) | ||||
Proceeds from the sale of Savvi business |
| 360 | ||||||
Net cash provided by investing activities |
8,228 | 1,521 | ||||||
Cash flows from financing activities: |
||||||||
Early extinguishments of convertible subordinated notes |
| (9,238 | ) | |||||
Principal payments on mortgage payable |
| (23 | ) | |||||
Proceeds from issuance of common stock |
4,091 | 684 | ||||||
Net cash provided by (used in) financing activities |
4,091 | (8,577 | ) | |||||
Effects of exchange rate changes |
(160 | ) | 72 | |||||
Net increase (decrease) in cash and cash equivalents |
19,032 | (6,947 | ) | |||||
Cash and cash equivalents, beginning of period |
149,925 | 33,138 | ||||||
Cash and cash equivalents, end of period |
$ | 168,957 | $ | 26,191 | ||||
The accompanying notes are an integral part of these financial statements.
5
RADISYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1 Significant Accounting Policies
RadiSys Corporation (the Company) has adhered to the accounting policies set forth in its Annual Report on Form 10-K for the year ended December 31, 2003 in preparing the accompanying interim Consolidated Financial Statements. The preparation of these statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. Actual results could differ from those estimates.
The financial information included herein reflects all normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the results for interim periods.
For the three months ended March 31, 2004, there have been no changes to these accounting policies except as noted below.
Reclassifications
Certain reclassifications have been made to amounts in prior years to conform to current year presentation. These changes had no effect on previously reported results of operations or shareholders equity.
Inventories
During the fourth quarter of 2003, the Company revised the excess and obsolete inventory (E&O) reserve calculation. The Company previously estimated the required reserve for excess inventory based on a forward projection of excess material beyond 12 months demand. The revised process takes into consideration the historical usage of materials over the prior six months and a prospective view of demand over 12 months. The Company tested the revised method against prior periods and found it to be a better indicator of excess inventory.
Accrued Restructuring
In July 2002, the Financial Accounting Standard Board (FASB) issued Statement of Financial Accounting Standard (SFAS) No. 146 Accounting for Costs Associated with Exit or Disposal Activities. SFAS No. 146 requires that liabilities for costs associated with exit or disposal activities be recognized and measured initially at fair value in the period in which the liabilities are incurred. For the year ended December 31, 2003, the Company recorded restructuring charges in accordance with the provisions of SFAS No. 146.
Prior to the year ended December 31, 2003, the Company recorded restructuring charges including employee termination and related costs, costs related to leased facilities, losses on impairment of fixed assets and capitalized software and other accounting and legal fees. Employee termination and related costs were previously recorded in accordance with the provisions of Emerging Issues Task Force No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity. For leased facilities that were vacated and subleased, an amount equal to the total future lease obligations from the date of vacating the premises through the expiration of the lease, net of any future sublease income, was recorded as a part of restructuring charges.
6
Warranty
The Company provides for the estimated cost of product warranties at the time it recognizes revenue. Products are generally sold with warranty coverage for a period of 24 months after shipment. Parts and labor are covered under the terms of the warranty agreement. The warranty provision is based on historical experience by product family. The Company engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its components suppliers; however, ongoing failure rates, material usage and service delivery costs incurred in correcting product failure, as well as specific product class failures out of the Companys baseline experience affect the estimated warranty obligation. If actual product failure rates, material usage or service delivery costs differ from estimates, revisions to the estimated warranty liability would be required.
The following is a summary of the change in the Companys warranty liability for the three months ended March 31, 2004 and 2003 (in thousands):
| For the Three Months Ended | ||||||||
| March 31, |
||||||||
| 2004 |
2003 |
|||||||
Warranty liability balance, beginning of the period |
$ | 2,276 | $ | 1,553 | ||||
Product warranty accruals |
1,149 | 1,147 | ||||||
Adjustments for payments made |
(1,497 | ) | (781 | ) | ||||
Warranty liability balance, end of the period |
$ | 1,928 | $ | 1,919 | ||||
The warranty liability balance is included in other accrued liabilities in the accompanying Consolidated Balance Sheets as of March 31, 2004 and December 31, 2003. The Company offers fixed price support or maintenance contracts to its customers. Revenues from fixed price support or maintenance contracts were not significant to the Companys operations for the periods reported.
Stock-based Compensation
The Company accounts for its stock-based compensation plans using the intrinsic value method and provides pro forma disclosures of net income (loss) and net income (loss) per common share as if the fair value method had been applied in measuring compensation expense. Equity instruments are not granted to non-employees, other than directors, as defined in the respective plan agreements.
Had RadiSys accounted for these plans under the fair value method, the Companys net income (loss) and pro forma net income (loss) per share would have been reported as follows (in thousands, except per share amounts):
| For the Three Months Ended March 31, |
||||||||
| 2004 |
2003 |
|||||||
Net income (loss) |
$ | 2,848 | $ | (4,246 | ) | |||
Add: Stock-based compensation
expense included in reported net
income (loss), net of related
tax effects |
115 | | ||||||
Deduct: Stock-based compensation
expense determined under fair
value method for all awards, net
of related tax effects |
(1,516 | ) | (1,668 | ) | ||||
Pro forma net income (loss) |
$ | 1,447 | $ | (5,914 | ) | |||
Net income (loss) per share: |
||||||||
Basic |
$ | 0.15 | $ | (0.24 | ) | |||
Diluted |
$ | 0.15 | $ | (0.24 | ) | |||
Pro forma basic |
$ | 0.08 | $ | (0.33 | ) | |||
Pro forma diluted |
$ | 0.07 | $ | (0.33 | ) | |||
During the three months ended March 31, 2004, the Company incurred $177 thousand of stock-based compensation expense associated with shares to be issued pursuant to the Companys 1996 Employee Stock Purchase Plan (ESPP). The Company incurred stock-based compensation expense because the original number of ESPP shares approved by the shareholders will be insufficient to meet employee demand for an ESPP offering
7
which was consummated in February 2003 and ends in August 2004. The Company subsequently received shareholder approval for additional ESPP shares in May 2003. The shares to be issued in the February 2003 ESPP offering in excess of the original number of ESPP shares approved at the beginning of the offering (the shortfall) triggers recognition of stock-based compensation expense under the intrinsic value method. The Company currently estimates the shortfall to amount to 121 thousand shares and 138 thousand shares to be issued in May 2004 and August 2004, respectively.
The expense per share is calculated as the difference between 85% of the closing price of RadiSys shares as quoted on NASDAQ on the date that additional ESPP shares were approved (May 2003) and the February 2003 ESPP offering purchase price. Accordingly, the expense per share is calculated as the difference between $8.42 and $5.48. The shortfall of shares is dependent on the amount of contributions from participants enrolled in the February 2003 ESPP offering.
The Company recognized stock-based compensation expense as follows (in thousands):
| For the Three Months Ended March 31, |
||||||||
| 2004 |
2003 |
|||||||
Cost of sales |
$ | 47 | $ | | ||||
Research and development |
74 | | ||||||
Selling, general and administrative |
56 | | ||||||
| $ | 177 | $ | | |||||
For the three months ended June 30, 2004 and September 30, 2004, the Company estimates stock-based compensation expense recognized under the intrinsic value method to amount to $380 thousand and $200 thousand, respectively.
Recent Accounting Pronouncements
In March 2004, the Emerging Issues Task Force (EITF) finalized it consensus on EITF Issue 03-6, Participating Securities and the Two-Class Method Under SFAS No. 128, Earnings Per Share ( EITF 03-6). EITF 03-6 clarifies what constitutes a participating security and requires the use of the two-class method for computing basic earnings per share when participating convertible securities exist. EITF 03-6 is effective for fiscal periods beginning after March 31, 2004. The Company does not expect the adoption of EITF 03-6 to have a material impact on the Companys financial position, results of operations or cash flows.
Note 2 Held-to-maturity Investments
Held-to-maturity investments consisted of the following (in thousands):
| March 31, | December 31, | |||||||
| 2004 |
2003 |
|||||||
Short-term held-to-maturity investments,
including unamortized premium of $671 and
$767, respectively |
$ | 41,629 | $ | 44,456 | ||||
Long-term held-to-maturity investments,
including unamortized premium of $209 and
$442, respectively |
$ | 23,859 | $ | 30,992 | ||||
As of March 31, 2004, the Companys long-term held-to-maturity investments had maturities ranging from 13.5 months to 28.8 months. The Companys investment policy requires that the total investment portfolio, including cash and investments, not exceed a maximum weighted-average maturity of 18 months. In addition, the policy mandates that an individual investment must have a maturity of less than 36 months, with no more than 20% of the total portfolio exceeding 24 months. As of March 31, 2004, the Company was in compliance with its investment policy.
8
Note 3 Accounts Receivable
Accounts receivable balances consisted of the following (in thousands):
| March 31, | December 31, | |||||||
| 2004 |
2003 |
|||||||
Accounts receivable, gross |
$ | 37,981 | $ | 33,445 | ||||
Less: allowance for doubtful accounts |
(1,190 | ) | (1,301 | ) | ||||
Accounts receivable, net |
$ | 36,791 | $ | 32,144 | ||||
The Company recorded no provisions for allowance for doubtful accounts during the three months ended March 31, 2004 and 2003.
Note 4 Inventories
Inventories consisted of the following (in thousands):
| March 31, | December 31, | |||||||
| 2004 |
2003 |
|||||||
Raw materials |
$ | 24,692 | $ | 28,992 | ||||
Work-in-process |
1,956 | 1,472 | ||||||
Finished goods |
3,666 | 5,119 | ||||||
| 30,314 | 35,583 | |||||||
Less: inventory reserves |
(8,791 | ) | (9,491 | ) | ||||
Inventories, net |
$ | 21,523 | $ | 26,092 | ||||
During the three months ended March 31, 2004 and 2003, the Company recorded provision for excess and obsolete inventory of $716 thousand and $1.3 million, respectively.
The following is a summary of the change in the Companys excess and obsolete inventory reserve for the three months ended March 31, 2004 and 2003 (in thousands):
| For the Three Months Ended | ||||||||
| March 31, |
||||||||
| 2004 |
2003 |
|||||||
Inventory reserve balance, beginning of the quarter |
$ | 9,491 | $ | 9,958 | ||||
Usage: |
||||||||
Inventory scrapped |
(667 | ) | (185 | ) | ||||
Inventory utilized |
(749 | ) | (649 | ) | ||||
Subtotal usage |
(1,416 | ) | (834 | ) | ||||
Reserve provision |
716 | 1,291 | ||||||
Remaining reserve balance, end of the quarter |
$ | 8,791 | $ | 10,415 | ||||
Note 5 Goodwill
During the three months ended March 31, 2003 the Company recorded goodwill write-offs of $2.4 million associated with the sale of its Savvi business line. The goodwill write-off associated with the sale of the Savvi business line is included in loss from discontinued operations in the accompanying Consolidated Statements of Operations for the three months ended March 31, 2003. See Note 13.
The Company tests goodwill for impairment at least annually. Additionally, the Company assesses goodwill for impairment if any adverse conditions exist that would indicate an impairment. Conditions that would trigger an impairment assessment, include, but are not limited to, a significant adverse change in legal factors or in the business climate that could affect the value of an asset or an adverse action or assessment by a regulator. If the carrying amount of an asset exceeds the sum of its undiscounted cash flows, the carrying value is written down to fair value in the period identified. Fair value is calculated as the present value of estimate future cash flows using a risk-adjusted discount rate commensurate with the Companys weighted-average cost of capital. The Company
9
completed its annual goodwill impairment analysis as of September 30, 2003 and concluded that as of September 30, 2003, there was no goodwill impairment. Management concluded there was no indication of material changes requiring an updated goodwill impairment analysis as of March 31, 2004.
10
Note 6 Intangible Assets
The following tables summarize details of the Companys total purchased intangible assets (in thousands):
| Accumulated | ||||||||||||
| Gross |
Amortization |
Net |
||||||||||
March 31, 2004 |
||||||||||||
Existing technology |
$ | 2,415 | $ | (1,223 | ) | $ | 1,192 | |||||
Technology licenses |
6,790 | (3,961 | ) | 2,829 | ||||||||
Patents |
6,647 | (5,465 | ) | 1,182 | ||||||||
Trade names |
736 | (184 | ) | 552 | ||||||||
Other |
237 | (237 | ) | | ||||||||
Total |
$ | 16,825 | $ | (11,070 | ) | $ | 5,755 | |||||
| Accumulated | ||||||||||||
| Gross |
Amortization |
Net |
||||||||||
December 31, 2003 |
||||||||||||
Existing technology |
$ | 2,415 | $ | (1,146 | ) | $ | 1,269 | |||||
Technology licenses |
6,790 | (3,584 | ) | 3,206 | ||||||||
Patents |
6,647 | (5,255 | ) | 1,392 | ||||||||
Trade names |
736 | (166 | ) | 570 | ||||||||
Other |
237 | (237 | ) | | ||||||||
Total |
$ | 16,825 | $ | (10,388 | ) | $ | 6,437 | |||||
The Companys purchased intangible assets have lives ranging from 4 to 11 years. The Company performs reviews for impairment of all its purchased intangible assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. As of March 31, 2004, management concluded there was no indication of events or changes in circumstances indicating that the carrying amount of purchased intangible assets may not be recoverable. The estimated future amortization expense of purchased intangible assets as of March 31, 2004 is as follows (in thousands):
| Estimated | ||||
| Intangible | ||||
| Amortization | ||||
| For the years ending December 31, |
Amount |
|||
2004 (remaining nine months) |
$ | 1,543 | ||
2005 |
||||